
Kazia Therapeutics Limited KZIA
€ 12.29
7.68%
Geschäftsbericht 2022
hinzugefügt 17.10.2022
Kazia Therapeutics Limited DSO 2011-2026 | KZIA
DSO Jährlich Kazia Therapeutics Limited
| 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| - | - | - | - | - | - | - | - | - | 28.7 | 18.8 | 923 |
Alle Zahlen in AUD-Währung
Indikatorenreichweite aus Jahresberichten
| Höchstwert | Mindestwert | Durchschnitt |
|---|---|---|
| 923 | 18.8 | 323 |
DSO anderer Aktien in der Pharmaeinzelhändler
| Name | DSO | Preis | % 24h | Marktkapitalisierung | Land | |
|---|---|---|---|---|---|---|
|
FSD Pharma
HUGE
|
2.94 K | - | 5743.5 % | $ 69.7 M | ||
|
AgeX Therapeutics
AGE
|
186 | - | -10.17 % | $ 12.2 K | ||
|
I-Mab
IMAB
|
271 | - | - | $ 866 M | ||
|
Midatech Pharma plc
MTP
|
204 | - | -18.52 % | $ 27.3 M | ||
|
Alexion Pharmaceuticals, Inc.
ALXN
|
84.7 | - | - | $ 40.3 B | ||
|
EyeGate Pharmaceuticals, Inc.
EYEG
|
2.75 K | - | -1.52 % | $ 24.7 M | ||
|
Exelixis
EXEL
|
43.4 | $ 48.16 | 4.22 % | $ 13.1 B | ||
|
Fortress Biotech
FBIO
|
115 | $ 2.39 | -0.42 % | $ 66.7 M | ||
|
Compugen Ltd.
CGEN
|
60.8 | $ 2.9 | 1.4 % | $ 271 M | ||
|
ACADIA Pharmaceuticals
ACAD
|
37.5 | $ 22.4 | -0.71 % | $ 3.71 B | ||
|
Genmab A/S
GMAB
|
97.9 | $ 26.43 | -2.33 % | $ 1.71 B | ||
|
Advaxis
ADXS
|
88.1 | - | -9.65 % | $ 45.9 M | ||
|
Esperion Therapeutics
ESPR
|
99.7 | $ 3.14 | - | $ 653 M | ||
|
Can-Fite BioPharma Ltd.
CANF
|
28.1 | $ 3.51 | -0.85 % | $ 5.78 M | ||
|
Aeterna Zentaris
AEZS
|
146 | - | 5.93 % | $ 314 M | ||
|
Gilead Sciences
GILD
|
57.8 | $ 131.33 | -2.04 % | $ 163 B | ||
|
Aeglea BioTherapeutics
AGLE
|
216 | - | - | $ 1.01 B | ||
|
CureVac N.V.
CVAC
|
13.6 | - | - | $ 867 M | ||
|
Applied Genetic Technologies Corporation
AGTC
|
0.114 | - | - | $ 26.5 M | ||
|
AIkido Pharma
AIKI
|
17.9 | - | 1.93 % | $ 17.4 M | ||
|
Aptinyx
APTX
|
46.9 | - | -39.0 % | $ 4.57 M | ||
|
Albireo Pharma
ALBO
|
14.7 | - | -0.23 % | $ 916 M | ||
|
Arcutis Biotherapeutics
ARQT
|
106 | $ 21.17 | 2.47 % | $ 2.69 B | ||
|
Alpine Immune Sciences
ALPN
|
154 | - | - | $ 2.17 B | ||
|
Aravive
ARAV
|
16.8 | - | -13.39 % | $ 1.45 M | ||
|
Aridis Pharmaceuticals
ARDS
|
59 | - | 17.91 % | $ 11.1 M | ||
|
CRISPR Therapeutics AG
CRSP
|
1.1 K | $ 54.83 | 4.6 % | $ 4.93 B | ||
|
Autolus Therapeutics plc
AUTL
|
58.2 | $ 1.57 | -2.48 % | $ 418 M |